共有 1 页
| 品牌 | 货号 | 包装单位 | 货期 | 产品名称 | 质量规格 | 单价(¥) | 购买数量 |
|---|---|---|---|---|---|---|---|
| 罗恩 | R023421-100mg | 100mg | 5~7个工作日 |
N-(2-(4-(2-甲氧基苯基)哌嗪-1-基)乙基)-... N-(2-(4-(2-Methoxyphenyl)pip... |
98% |
|
|
| 罗恩 | R023421-25mg | 25mg | 5~7个工作日 |
N-(2-(4-(2-甲氧基苯基)哌嗪-1-基)乙基)-... N-(2-(4-(2-Methoxyphenyl)pip... |
98% |
|
|
| 阿拉丁 | W124987-5mg | 5mg | 现货 |
WAY-100635,5-HT1A受体拮抗剂 WAY-100635 |
Moligand™, ≥98% |
|
|
| 阿拉丁 | W124987-25mg | 25mg | 现货 |
WAY-100635,5-HT1A受体拮抗剂 WAY-100635 |
Moligand™, ≥98% |
|
|
| 阿拉丁 | W124987-100mg | 100mg | 现货 |
WAY-100635,5-HT1A受体拮抗剂 WAY-100635 |
Moligand™, ≥98% |
|
|
| 阿拉丁 | W1493687-1ml | 1ml | 期货,请咨询 |
WAY-100635 WAY-100635 |
Moligand™, 10 mM in DMSO |
|
|
| 凯为 | JZ001UF2-5mg | 5mg | 现货 |
N-(2-(4-(2-甲氧基苯基)哌嗪-1-基)乙基)-... WAY-100635 |
99% |
|
|
| 凯为 | JZ001UF2-10mg | 10mg | 现货 |
N-(2-(4-(2-甲氧基苯基)哌嗪-1-基)乙基)-... WAY-100635 |
99% |
|
|
| 凯为 | JZ001UF2-25mg | 25mg | 现货 |
N-(2-(4-(2-甲氧基苯基)哌嗪-1-基)乙基)-... WAY-100635 |
99% |
|
|
| 凯为 | JZ001UF2-50mg | 50mg | 现货 |
N-(2-(4-(2-甲氧基苯基)哌嗪-1-基)乙基)-... WAY-100635 |
99% |
|
|
| 凯为 | JZ001UF2-100mg | 100mg | 现货 |
N-(2-(4-(2-甲氧基苯基)哌嗪-1-基)乙基)-... WAY-100635 |
99% |
|
|
| 毕得 | BD424436-10mg | 10mg | 现货 |
N-(2-(4-(2-甲氧基苯基)哌嗪-1-基)乙基)-... N-(2-(4-(2-Methoxyphenyl)pip... |
99% |
|
|
| 毕得 | BD424436-50mg | 50mg | 现货 |
N-(2-(4-(2-甲氧基苯基)哌嗪-1-基)乙基)-... N-(2-(4-(2-Methoxyphenyl)pip... |
99% |
|
|
| 毕得 | BD424436-100mg | 100mg | 现货 |
N-(2-(4-(2-甲氧基苯基)哌嗪-1-基)乙基)-... N-(2-(4-(2-Methoxyphenyl)pip... |
99% |
|
|
| 毕得 | BD424436-25mg | 25mg | 现货 |
N-(2-(4-(2-甲氧基苯基)哌嗪-1-基)乙基)-... N-(2-(4-(2-Methoxyphenyl)pip... |
99% |
|
|
| 毕得 | BD424436-5mg | 5mg | 现货 |
N-(2-(4-(2-甲氧基苯基)哌嗪-1-基)乙基)-... N-(2-(4-(2-Methoxyphenyl)pip... |
99% |
|
|
| solarbio | IYT28451-1ml | 1ml | 请咨询 | WAY-100635(10mM in DMSO,Ster... |
|
|
|
| solarbio | IYT28459-1ml | 1ml | 请咨询 | WAY-100635(10mM in DMSO) |
|
|
|
| solarbio | IYT2845-5mg | 5mg | 请咨询 | WAY-100635 |
|
|
|
| solarbio | IYT2845-10mg | 10mg | 请咨询 | WAY-100635 |
|
|
|
| solarbio | IYT2845-50mg | 50mg | 请咨询 | WAY-100635 |
|
|
|
| 安耐吉 | M0139573-100mg | 100mg | 现货 |
N-(2-(4-(2-甲氧基苯基)哌嗪-1-基)乙基)-... N-(2-(4-(2-methoxyphenyl)pip... |
95% |
|
|
| 安耐吉 | M0139573-50mg | 50mg | 现货 |
N-(2-(4-(2-甲氧基苯基)哌嗪-1-基)乙基)-... N-(2-(4-(2-methoxyphenyl)pip... |
95% |
|
|
| 安耐吉 | M0139573-10mg | 10mg | 现货 |
N-(2-(4-(2-甲氧基苯基)哌嗪-1-基)乙基)-... N-(2-(4-(2-methoxyphenyl)pip... |
95% |
|
|
| 安耐吉 | M0139573-25mg | 25mg | 现货 |
N-(2-(4-(2-甲氧基苯基)哌嗪-1-基)乙基)-... N-(2-(4-(2-methoxyphenyl)pip... |
95% |
|
|
| 安耐吉 | M0139573-5mg | 5mg | 现货 |
N-(2-(4-(2-甲氧基苯基)哌嗪-1-基)乙基)-... N-(2-(4-(2-methoxyphenyl)pip... |
95% |
|
|
| 源叶 | Y27848-5mg | 5mg | 现货 |
WAY-100635,5-HT1A受体拮抗剂 WAY-100635 |
≥98% |
|
|
| 源叶 | Y27848-25mg | 25mg | 现货 |
WAY-100635,5-HT1A受体拮抗剂 WAY-100635 |
≥98% |
|
|
| 源叶 | Y27848-100mg | 100mg | 现货 |
WAY-100635,5-HT1A受体拮抗剂 WAY-100635 |
≥98% |
|
|
| 源叶 | V51814-1ml | 1ml | 期货,请咨询 |
WAY-100635,5-HT1A受体拮抗剂 WAY-100635 |
10mM in DMSO |
|
|
| Target Mol | T21561-50mg | 50 mg | 期货,请咨询 |
化合物 WAY-100635 WAY-100635 |
98.97% |
|
|
| Target Mol | T21561-100mg | 100 mg | 期货,请咨询 |
化合物 WAY-100635 WAY-100635 |
98.97% |
|
|
| Target Mol | T21561-5mg | 5 mg | 现货 |
化合物 WAY-100635 WAY-100635 |
98.97% |
|
|
| Target Mol | T21561-1mg | 1 mg | 现货 |
化合物 WAY-100635 WAY-100635 |
98.97% |
|
|
| Target Mol | T21561-10mg | 10 mg | 现货 |
化合物 WAY-100635 WAY-100635 |
98.97% |
|
|
| Target Mol | T21561-25mg | 25 mg | 现货 |
化合物 WAY-100635 WAY-100635 |
98.97% |
|
|
| Target Mol | T21561-1mLx10mM(inDMSO) | 1 mL x 10 mM (in DMSO) | 现货 |
化合物 WAY-100635 WAY-100635 |
98.97% |
|
|
| MCE | HY-10349-100mg | 100mg | 现货 |
WAY-100635 WAY-100635 |
99.32% |
|
|
| MCE | HY-10349-50mg | 50mg | 现货 |
WAY-100635 WAY-100635 |
99.32% |
|
|
| MCE | HY-10349-10mg | 10mg | 现货 |
WAY-100635 WAY-100635 |
99.32% |
|
|
| MCE | HY-10349-5mg | 5mg | 现货 |
WAY-100635 WAY-100635 |
99.32% |
|
|